- Home
- PRFX
PRFX
PainReform Ltd.
as 07-26-2024 4:00pm EST
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
| Founded: | 2007 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 1.2M | IPO Year: | 2020 |
| Target Price: | $2.00 | AVG Volume (30 days): | 172.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.66 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.38 - $8.59 | Next Earning Date: | 08-08-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest PainReform Ltd. News
PRFX Breaking Stock News: Dive into PRFX Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
PainReform Files Patent Covering Highly Scalable Manufacturing Process for PRF-110 Following Successful Completion and Testing
GlobeNewswire
a month ago
PainReform Completes Enrollment in the Second Part of its Phase 3 Bunionectomy Trial for PRF-110
Investor's Business Daily
2 months ago
IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses
Business Wire
2 months ago
Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library
Investor's Business Daily
2 months ago
Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap
GlobeNewswire
2 months ago
EnviroGold Global Closes First Tranche of Private Placement
GuruFocus.com
2 months ago
Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)
Yahoo Finance Video
2 months ago
How markets digested hot jobs print: Top takeaways
Compare PRFX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRFX PainReform Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.